By elucidating the intricate interplay between LL37, TLR2, and JAK2/STAT3 signaling in mast cells, our findings provide novel mechanistic insights into rosacea pathogenesis and lay the groundwork for the development of targeted therapies. Here, JAK2 is linked to rosacea.